Brandon Torres Declet - May 14, 2024 Form 4 Insider Report for Workhorse Group Inc. (WKHS)

Role
Director
Signature
/s/ Arthur McMahon III, attorney-in-fact for Brandon Torres Declet
Stock symbol
WKHS
Transactions as of
May 14, 2024
Transactions value $
-$33,123
Form type
4
Date filed
5/16/2024, 07:32 PM
Previous filing
Feb 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WKHS Common Stock, $0.001 par value per share Options Exercise $0 +158K +140.85% $0.00 270K May 14, 2024 Direct F1
transaction WKHS Common Stock, $0.001 par value per share Disposed to Issuer -$33.1K -158K -58.48% $0.21 112K May 14, 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WKHS Restricted Stock Units Options Exercise $0 -158K -100% $0.00* 0 May 14, 2024 Common Stock, $0.001 par value per share 158K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of common stock of Workhorse Group Inc. (the "Company"), vesting on August 21, 2024. Upon vesting, the RSUs may be settled in cash at the discretion of the Company's Board of Directors or Compensation Committee. If the reporting person is no longer a director of the Company on August 21, 2024 by reason of death, disability, or not standing for re-election, the RSUs will vest pro rata based on the number of board meetings attended by the grantee in 2024, as compared to the total number of scheduled board meetings in 2024 between the grant date and the six-month anniversary thereof. The stock price reflected in Table I Column 4 was determined based on fair market value as the closing trading price of the Company's common stock on the grant date.
F2 Pursuant to the terms of the Award Agreement, all of the RSUs that vested were settled in cash.
F3 Reflects the removal of 315,457 RSUs that were originally reported as common stock and were subsequently reported as derivatives by amendment.